Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Zura Bio Limited Class A Ordinary Shares

ZURA
Current price
3.6 USD -0.8 USD (-18.18%)
Last closed 4.38 USD
Company
ISIN KYG9TY5A1016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 292 085 824 USD
Yield for 12 month -17.62 %
1Y
3Y
5Y
10Y
15Y
ZURA
21.11.2021 - 28.11.2021

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada. Address: 1489 W. Warm Springs Road, Henderson, NV, United States, 89014

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15 USD

P/E ratio

8.0351

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

-1 000 USD

Key Figures ZURA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM
PE Ratio 8.0351
Return On Assets TTM -21.4 %
PEG Ratio
Return On Equity TTM -36.85 %
Wall Street Target Price 15 USD
Revenue TTM
Book Value 2.34 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share 0.57 USD
Diluted Eps TTM 0.57 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ZURA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ZURA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ZURA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 8.0351
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.3439
Price Book MRQ 1.8661

Financials ZURA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ZURA

For 52 weeks

2 USD 6.35 USD
50 Day MA 4.18 USD
Shares Short Prior Month 1 857 247
200 Day MA 3.86 USD
Short Ratio 2.88
Shares Short 1 882 743
Short Percent 3.58 %